The Weill Department of Medicine is deeply saddened by the loss of Dr. Bruce Gordon, a long-time, highly distinguished member of our faculty, who passed away on Monday after a prolonged illness.
Dr. Gordon’s clinical interest in lipid disorders led to his groundbreaking work in the development of numerous therapies for hyperlipidemia, including lipid apheresis. His expertise was particularly beneficial for salvaging kidney allografts undergoing kidney antibody mediated rejection and thrombotic microangiopathy. Dr. Gordon’s remarkable clinical contributions were rivaled only by his renowned strengths as a teacher. He will be greatly missed for his warmth, collegiality, exceptional clinical skills, dedication to his patients, scholarship, and unmatched mentorship.
A Professor of Clinical Medicine in both the Weill Department of Medicine (Division of Nephrology and Hypertension) and the Department of Surgery, Dr. Gordon was also a member of the Board of Directors of the Rogosin Institute, where he also served as Executive Vice President for Strategy. After receiving his M.D. from Yale School of Medicine, Dr. Gordon served as intern, resident, and assistant chief resident at NewYork- Presbyterian/Weill Cornell Medical Center. He also completed a fellowship in hematology at Weill Cornell. He was a member of the Arteriosclerosis council of the American Heart Association and a member of the International Society for Apheresis.
He is survived by his wife Stasi Lubansky, D.N.P., an internist at Weill Cornell Internal Medical Associates (WCIMA), and their three children: William, a graduate of Weill Cornell Medical College, Julia, and Emily. Services will take place this Thursday, March 27 at 9:30 a.m. at Plaza Jewish Community Chapel, 630 Amsterdam Ave (at 91st St). Stasi and her family will sit Shiva on Thursday and Friday, March 28 from 4 to 7 p.m. at 875 West End Ave (at 103rd) #14F.
Related Links: In Memoriam
Dr. Manikkam Suthanthiran
Chief, Division of Nephrology and Hypertension
Dr. Jeffrey Silberzweig
Professor of Clinical Medicine, Division of Nephrology and Hypertension
Chief Medical Officer, The Rogosin Institute
Dr. John Leonard
Chair (Interim), Joan and Sanford I. Weill Department of Medicine